Table 2.
Demographics of the study population
| Demographic variables | Study population (n = 66) |
|---|---|
| Gender (male) | 41 (62%) |
| Height (cm) | 166.3 ± 7.9 |
| BMI (kg/m2) | 26.9 ± 4.5 |
| Age (years) | 73 ± 12 |
| Smoking | 17 (26%) |
| Fistula | 27 (41%) |
| Hickmann Catheter | 39 (59%) |
| KT/V | 1.41 ± 0.20 |
| Dialysis vintage (months) | 49.2 ± 46.8 |
| Median UFV (mL) | 1800 [1100–2400] |
| Predialysis SBP/DBP (mmHg) | 134.9 ± 22.1 / 64.3 ± 15.0 |
| Postdialysis SBP/DBP (mmHg) | 129.5 ± 20.3 / 63.5 ± 12.6 |
| Etiology of End-Stage Renal Disease | |
| Diabetic Kidney Disease | 16 (24%) |
| Non-diabetic Kidney Disease | 53 (80%) |
| Comorbidities | |
| Cardiac Diseasea | 39 (59%) |
| Lung Disease (COPD) | 7 (11%) |
| Arterial Hypertension | 47 (71%) |
| Diabetes | 29 (44%) |
| Overweight | 26 (39%) |
| Obesity | 15 (23%) |
aCardiac diseases identified within the study population: cardiomyopathy, systolic dysfunction, ischemic heart failure, decompensated heart failure, heart failure with reduced ejection fraction, coronary artery bypass grafting surgery, aortic valve stenosis and replacement, myocardial infarction, ventricular fibrillation and flutter, the presence of cardiac implantable electronic devices (e.g. pacemaker), atrial fibrillation, bundle branch block, left ventricular hypertrophy
COPD chronic obstructive pulmonary disease; DBP diastolic blood pressure; SBP systolic blood pressure; UFV ultrafiltration volume